Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Journal of Medicinal Chemistry Année : 2019

Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells

Dates et versions

hal-02526957 , version 1 (31-03-2020)

Identifiants

Citer

Amélie Fouqué, Olivier Delalande, Mickael Jean, Rémy Castellano, Emmanuelle Josselin, et al.. Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells. Journal of Medicinal Chemistry, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩. ⟨hal-02526957⟩
43 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More